Phase 3
๐ Investigational Drug / Biologic
NCT07104032
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
๐ Mayo Clinic Cancer Center โ Phoenix, Arizona
View Study & Screener โ